Skip to content
AnalystLens
Back to MRNABalance Sheet

Moderna, Inc. Other Non-current Assets 2017-2026 | MRNA

Annual FY2017–FY2025 · quarterly through Q1 FY2026

Latest annual · FY2025

$605.0M

+1.9%YoY vs FY2024Source: 10-KFY2025

From $4.6M in FY2017 to $605.0M in FY2025: 131.9× in 8 years.

By quarter▲▼ vs a year before
Fiscal yearQ1Q2Q3Q4
FY26$675M+21.4%Not reportedNot reportedNot reported
FY25$556M−14.5%$546M−14.8%$530M−4.7%$605M+1.9%
FY24$650M−44.2%$641M−50.3%$556M−15.9%$594M−22.5%
FY23$1.2B+1319.5%$1.3B+1620.0%$661M+1639.5%$766M−22.5%
FY22$82M+8100.0%$75M+3650.0%$38M+850.0%$988M+2047.8%

Shaded by size: darkest is the largest quarter shown; ringed is the latest reported; a dash marks a quarter with no separate figure. Each quarter sits by its period-end date.

Key Statistics

Trend DirectionStable
CAGR

+213.4%

FY2020
$2.0M
FY2025
$605.0M

5 years selected · on the chart

Other Non-current Assets History

Year-over-year comparison from 10-K annual reports

  1. $605.0M
YoY changeLargest recent move+2047.8%in FY22Latest +1.9%

2 older moves run past ±150% (largest +2200.0%); point at, tap or drag across the bars to read one.

Other Non-current Assets, period by period

PeriodValueChangeSource
FY2025$605.0M+1.9%10-K
FY2024$594.0M−22.5%10-K
FY2023$766.0M−22.5%10-K
FY2022$988.0M+2047.8%10-K
FY2021$46.0M+2200.0%10-K
FY2020$2.0M+3.6%10-K
FY2019$1.9M−27.0%10-K
FY2018$2.6M−42.3%10-K
FY2017$4.6M—10-K

What is Moderna, Inc.'s current other non-current assets?

Moderna, Inc. (MRNA) annual other non-current assets for 2025 was $605.0M, a 1.85% increase from 2024. Moderna, Inc. other non-current assets for the quarter ending March 31, 2026 was $675.0M.

What was Moderna, Inc.'s other non-current assets in 2024?

Moderna, Inc. annual other non-current assets for 2024 was $594.0M, a 22.45% decline from 2023.

What was Moderna, Inc.'s other non-current assets in 2023?

Moderna, Inc. annual other non-current assets for 2023 was $766.0M, a 22.47% decline from 2022.

What is Moderna, Inc.'s 5-year other non-current assets CAGR?

Moderna, Inc. other non-current assets grew at a compound annual growth rate (CAGR) of 213.43% from FY2020 to FY2025, going from $2.0M to $605.0M over 5 years.

Company
Moderna, Inc.
Ticker
MRNA
Sector
Healthcare
Industry
Biological Products, (No Diagnostic Substances)